Cellular and molecular deregulations driving the metastatic phenotype;Dérèglements cellulaires et moléculaires à Porigine du phénotype métastatique

Medecine/Sciences

Volumn 25, Issue SPEC. ISS. 1, 2009, Pages 29-32

  Zeitoun, Guy ^a  

^a Centre Hospitalier Francois Quesnay   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; WNT PROTEIN;

ARTICLE; CANCER STEM CELL; CELL MIGRATION; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; DISTANT METASTASIS; DNA REPLICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; METASTASIS; MOLECULAR MECHANICS;

EID: 64649087425     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2009251s29     Document Type: Article

References (20)

1. Boman BM, Huong E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 2008 ; 26 : 2828-38.
2. Scoville DH, Sato T, He XC, Li L Current view: intestinal stem cells and signaling. Gastroenterology 2008 ; 134 : 849-64.
3. Sääf AM, Halbleib JM, Chen X, et a/. Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mot Biol Cell 2007 ; 18 : 4245-60.
4. Van den Brink GR, Offerhaus GJ. The morphogenetic code and colon cancer development. Cancer Cell 2007; 11: 109-17.
5. Fodde R. The multiple functions of tumour suppressors: it's all in APC. Nat Cell Biol 2003 ; 5: 190-2.
6. Buckowitz A, Knaebel HP, Benner A, et al. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer 2005; 92: 1746-53.
7. Zeitoun G, Buecher B, Bayer J, et al. Retention of chromosome arm 5q in stage II colon cancers identifies 83 % of liver metastasis occurrences. Genes Chrom Cancer 2006 ; 45:94-102.
8. Albuquerque C, Breukel C, Van der Luijt R, et al. The just-right signalling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signalling cascade. Hum Mol Genet 2002 ; 11 : 1549-60.
9. Suzuki H, Masuda N, Shimura T, et al. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res 2008 ; 28 : 1821-30.
10. Prochownik EV. c-Myc: linking transformation and genomic instability. Can Mol Med 2008; 8: 446-58.
11. Al-Mulla F, AlFadhli S, Al-Hakim AH, et al. Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q. J Clin Pathol 2006 ; 59 : 624-30.
12. Tassi E, Wellstein A. The angiogenic switch molecule, secreted FGF- binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma. Semin Oncol 2006 ; 33 (suppi 11): S50-6.
13. Mourra N, Zeitoun G, Portier G, et al. High-resolution genotyping of chromosome 8 in colon adenocarcinomas reveals recurrent break point but no gene mutation in the 8p21 region. Diagn Mol Pathol 2008 ; 17:90-3.
14. Brocardo M, Lei y, Tighe A, et al. Mitochondrial targeting of adenomatous polyposis coli protein is stimulated by truncating cancer mutations: regulation of Bcl-2 and implications for cell survival J Biol Chem 2008 ; 283:5950-9.
15. Horak CE, Steeg PS. Metastasis gets site specific. Cancer Cell 2005 ; 8:93-5.
16. Dimberg J, Hugander A, Löfgren S, Wågsäter D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med 2007; 19: 11-5.
17. Zeitoun G, Mourra N, Blanche-Koch H, Thomas G, Olschwang S. Genomic profile of colon cancer metastases. Anticancer Res 2008 ; 28 : 3609-12.
18. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007 ; 1775:21-62.
19. Lash GE, Otun HA, Innes BA, et al. Inhibition of trophoblast cell invasion by TGFB1, 2, and 3 is associated with a decrease in active proteases. Biol Reprod 2005; 73: 374-81.
20. Allgayer H, Aguirre-Ghiso JA. The urokinase receptor (u-PAR): a link between tumor cell dormancy and minimal residual disease in bone marrow? APMIS 2008; 116:602-14.